Repression of IRF-4 target genes in human T cell leukemia virus-1 infection

Oncogene

Volumn 21, Issue 44, 2002, Pages 6751-6765

  Mamane, Yaël ^a   Grandvaux, Nathalie ^a   Hernandez, Eduardo ^a   Sharma, Sonia ^a   Innocente, Steve A ^b   Lee, Jonathan M ^b   Azimi, Nazli ^c   Lin, Rongtuan ^a   Hiscott, John ^a  

^a MCGILL UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cyclin B1; Human T cell leukemia virus; Interferon regulatory factors; Transcription

Indexed keywords

CYCLIN B1; INTERFERON REGULATORY FACTOR 4; PROTEIN KINASE;

ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; CYTOSKELETON; DNA REPAIR; ENZYME ACTIVITY; GENE CONTROL; GENE REPRESSION; GENE TECHNOLOGY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LEUKEMOGENESIS; METASTASIS; MITOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTECTION; T CELL LEUKEMIA; VIRUS CARCINOGENESIS;

BASE SEQUENCE; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON REGULATORY FACTORS; JURKAT CELLS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; RNA VIRUSES;

EID: 0037015679     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205843     Document Type: Article

References (108)

1. Arthur WT and Burridge K. (2001). Mol. Biol. Cell, 12, 2711-2720.
2. Bochkareva E, Korolev S and Bochkarev A. (2000). J. Biol. Chem., 275, 27332-27338.
3. Brass A, Kehrli E, Eisenbeis C, Storb U and Singh H. (1996). Genes Dev., 10, 2335-2347.
4. Brien TP, Depowski PL, Sheehan CE, Ross JS and McKenna BJ. (1998). Mod. Pathol., 11, 870-877.
5. Bruick RK. (2000). Proc. Natl. Acad. Sci. USA, 97, 9082-9087.
6. Campbell M, Chan G and Yen T. (2001). J. Cell Sci., 114, 953-963.
7. Cann A and Chen I. (1996). Fields Virology. Fields B (ed). 1849 pp. Philadelphia: Lippincott-Raven.
8. Cannavo G, Paiardini M, Galati D, Cervasi B, Montroni M, De Vico G, Guetard D, Bocchino ML, Picerno I, Magnani M, Silvestri G and Piedimonte G. (2001). Blood, 97, 1756-1764.
9. Carbone A, Gloghini A, Cozzi MR, Capello D, Steffan A, Monini P, De Marco L and Gaidano G. (2000). Br. J. Haematol., 111, 247-257.
10. Carbone A, Gloghini A, Larocca LM, Capello D, Pierconti F, Canzonieri V, Tirelli U, Dalla-Favera R and Gaidano G. (2001). Blood, 97, 744-751.
11. Chapman HA, Wei Y, Simon DI and Waltz DA. (1999). Thromb. Haemost., 82, 291-297.
12. Chatterjee D, Wyche JH and Pantazis P. (2000). Anticancer Res., 20, 4477-4782.
13. Chu ZL, Shin YA, Yang JM, DiDonato JA and Ballard DW. (1999). J. Biol. Chem., 274, 15297-15300.
14. Clark PR and Menoret A. (2001). Cell Stress Chaperones, 6, 121-125.
15. Cogswell JP, Godlevski MM, Bonham M, Bisi J and Babiss L. (1995). Mol. Cell. Biol., 15, 2782-2790.
16. Dianov GL, Jensen BR, Kenny MK and Bohr VA. (1999). Biochemistry, 38, 11021-11025.
17. Dib K. (2000). Front Biosci., 5, D438-D451
18. Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse CK, Eaton A, Mohrenweiser HW, Newman B and Bell DA. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 217-222.
19. Edlich RF, Arnette JA and Williams FM. (2000). J. Emerg. Med., 18, 109-119.
20. Eisenbeis CF, Singh H and Storb U. (1995). Genes Dev., 9, 1377-1387.
21. Gaidano G and Carbone A. (2000). Leukemia, 14, 563-566.
22. Grumont RJ and Gerondakis S. (2000). J. Exp. Med., 191, 1281-1292.
23. Gupta S, Anthony A and Pernis AB. (2001). J. Immunol., 166, 6104-6111.
24. Gupta S, Jiang M, Anthony A and Pernis AB. (1999). J. Exp. Med., 190, 1837-1848.
25. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
26. Hapke S, Gawaz M, Dehne K, Kohler J, Marshall JF, Graeff H, Schmitt M, Reuning U and Lengyel E. (2001). Mol. Cell Biol., 21, 2118-2132.
27. Himmelmann A, Riva A, Wilson GL, Lucas BP, Thevenin C and Kehrl JH. (1997). Blood, 90, 3984-3995.
28. Hiscott J, Kwon H and Genin P. (2001). J. Clin. Invest., 107, 143-151.
29. Hrdlickova R, Nehyba J and Bose Jr HR. (2001). Mol. Cell Biol., 21, 6369-6386.
30. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RSK and Dalla-Favera R. (1997). Nat. Genet., 17, 226-230.
31. Imaizumi Y, Kohno T, Yamada Y, Ikeda S, Tanaka Y, Tomonaga M and Matsuyama T. (2001). Jpn. J. Cancer Res., 92, 1284-1292.
32. Innocente SA, Abrahamson JL, Cogswell JP and Lee JM. (1999). Proc. Natl. Acad. Sci. USA, 96, 2147-2152.
33. Israel A. (2000). Trends Cell Biol., 10, 129-133.
34. Itoyama T, Chaganti RS, Yamada Y, Tsukasaki K, Atogami S, Nakamura H, Tomonaga M, Ohshima K, Kikuchi M and Sadamori N. (2001). Blood, 97, 3612-3620.
35. Iwanaga R, Ohtani K, Hayashi T and Nakamura M. (2001). Oncogene, 20, 2055-2067.
36. Jackman MR and Pines JN. (1997). Cancer Surv., 29, 47-73.
37. Jin D-Y, Spencer F and Jeang K-T. (1998). Cell, 93, 81-91.
38. Johnson DG and Walker CL. (1999). Annu. Rev. Pharmacol. Toxicol., 39, 295-312.
39. Kaida A, Ariumi Y, Ueda Y, Lin JY, Hijikata M, Ikawa S and Shimotohno K. (2000). Oncogene, 19, 827-830.
40. Kamada N, Sakurai M, Miyamoto K, Sanada I, Sadomori N, Fukuhara S, Abe S, Shiraishi Y, Abe T and Kaneko Y. (1992). Cancer Res., 52, 1481-1493.
41. Karin M. (1999a). J. Biol. Chem., 274, 27339-27342.
42. Karin M. (1999b). Oncogene, 18, 6867-6874.
43. Kasai T, Iwanaga Y, Iha H and Jeang KT. (2001). J. Biol. Chem., 29, 29.
44. Katula KS, Wright KL, Paul H, Surman DR, Nuckolls FJ, Smith JW, Ting JP, Yates J and Cogswell JP. (1997). Cell Growth Differ., 8, 811-820.
45. Lacana E, Ganjei JK, Vito P and D'Adamio L. (1997). J. Immunol., 158, 5129-5135.
46. Lemasson I and Nyborg JK. (2001). J. Biol. Chem., 276, 15720-15727.
47. Lemoine FJ and Marriott SJ. (2001). J. Biol. Chem., 276, 31851-31857.
48. Lengauer C, Kinzler KW and Vogelstein B. (1998). Nature, 396, 643-649.
49. Leung TW, Lin SS, Tsang AC, Tong CS, Ching JC, Leung WY, Gimlich R, Wong GG and Yao KM. (2001). FEBS Lett., 507, 59-66.
50. Lin R, Heylbroeck C, Genin P, Pitha P and Hiscott J. (1999). Mol. Cell Biol., 19, 959-966.
51. Liu A, Cerniglia GJ, Bernard EJ and Prendergast GC. (2001a). Proc. Natl. Acad. Sci. USA, 98, 6192-6197.
52. Liu AX, Rane N, Liu JP and Predergast GC. (2001b). Mol. Cell. Biol., 21, 6906-6912.
53. Lo KW, Zhang Q, Li M and Zhang M. (1999). Biochemistry, 38, 7498-7508.
54. Louvet-Vallee S. (2000). Biol. Cell, 92, 305-316.
55. Mamane Y, Heylbroeck C, Genin P, Algarte M, Servant MJ, LePage C, DeLuca C, Kwon H, Lin R and Hiscott J. (1999). Gene, 237, 1-14.
56. Mamane Y, Sharma S, Grandvaux N, Hernandez E and Hiscott J. (2002). J. Interferon Cytokine Res., 22, 135-143.
57. Mamane Y, Sharma S, Petropoulos L, Lin R and Hiscott J. (2000). Immunity, 12, 129-140.
58. Manjili MH, Wang XY, Park J, Facciponte JG, Repasky EA and Subjeck JR. (2002). Front Biosci., 7, D43-D52.
59. Marecki S and Fenton MJ. (2000). Cell Biochem. Biophys., 33, 127-148.
60. Marecki S, Riendeau CJ, Liang MD and Fenton MJ. (2001). J. Immunol., 166, 6829-6838.
61. Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ and Dutta A. (1996). Cancer Res., 56, 4159-4163.
62. Maytin EV, Ubeda M, Lin JC and Habener JF. (2001). Exp. Cell Res., 267, 193-204.
63. Meraro D, Hashmueli S, Koren B, Azriel A, Oumard A, Kirchhoff S, Hauser H, Nagulapalli S, Atchison ML and Levi BZ. (1999). J. Immunol., 163, 6468-6478.
64. Mittrucker H-W, Matsuyama T, Grossman A, Kundig TM, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi P and Mak TW. (1997). Science, 275, 540-543.
65. Molinari M. (2000). Cell Prolif., 33, 261-274.
66. Muchardt C and Yaniv M. (2001). Oncogene, 20, 3067-3075.
67. Murakami H, Furihata M, Ohtsuki Y and Ogoshi S. (1999). Virchows Arch., 434, 153-158.
68. Nagulapalli S and Atchison ML. (1998). Mol. Cell. Biol., 18, 4639-4650.
69. Neuveut C and Jeang KT. (2002). Front. Biosci., 7, D157-D163.
70. Ng T, Parsons M, Hughes WE, Monypenny J, Zicha D, Gautreau A, Arpin M, Gschmeissner S, Verveer PJ, Bastiaens PI and Parker PJ. (2001). EMBO J., 20, 2723-2741.
71. Nilsson I and Hoffmann I. (2000). Prog. Cell Cycle Res., 4, 107-114.
72. O'Connor PM. (1997). Cancer Surv., 29, 151-182.
73. Ohshima K, Suzumiya J, Sato K, Kanda M, Simazaki T, Kawasaki C, Haraoka S and Kikuchi M. (1999). J. Pathol., 189, 539-545.
74. Pawlak G and Helfman DM. (2001). Curr. Opin. Genet. Dev., 11, 41-47.
75. Pise-Masison CA, Choi KS, Radonovich M, Dittmer J, Kim SJ and Brady JN. (1998). J. Virol., 72, 1165-1170.
76. Pise-Masison CA, Mahieux R, Jiang H, Ashcroft M, Radonovich M, Duvall J, Guillerm C and Brady JN. (2000a). Mol. Cell Biol., 20, 3377-3386.
77. Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Duvall J, Guillerm C and Brady JN. (2000b). AIDS Res. Hum. Retroviruses, 16, 1669-1675.
78. Porter LA, Singh G and Lee JM. (2000). Blood, 95, 2645-2650.
79. Poullet P, Gautreau A, Kadare G, Girault JA, Louvard D and Arpin M. (2001). J. Biol. Chem., 276, 37686-37691.
80. Rosenbauer F, Waring JF, Foerster J, Wietstruk M, Philipp D, Horak I. (1999). Blood 94, 4274-4281.
81. Sadamori N. (1991). Cancer Genet Cytogenet., 51, 131-136.
82. Sadamori N, Isobe M, Shimizu S, Yamamori T, Itoyama T, Ikeda S, Yamada Y and Ichimaru M. (1991). Acta Haematol., 86, 14-19.
83. Satoh S and Tominaga T. (2001). J. Biol. Chem., 276, 39290-39294.
84. Schmidt M, Hochhaus A, Konig-Merediz SA, Brendel C, Proba J, Hoppe GJ, Wittig B, Enhinger G, Hehlmann R and Neubauer A. (2000). J. Clin. Oncol., 18, 3331-3338.
85. Seasholtz TM, Majumdar M and Brown JH. (1999). Mol. Pharmacol., 55, 949-956.
86. Senderowicz AM. (2000). Oncogene, 19, 6600-6606.
87. Senderowicz AM and Sausville EA. (2000). J. Natl. Cancer Inst., 92, 376-387.
88. Sharma S, Grandvaux N, Mamane Y, Genin P, Azimi N, Waldmann TA and Hiscott J. (2002). J. Immunol. in press.
89. Sharma S, Mamane Y, Grandvaux N, Bartlett J, Petropoulos L, Lin R and Hiscott J. (2000). AIDS Res. Hum. Retroviruses, 16, 1613-1622.
90. Song Y, Wong C and Chang DD. (2000). J. Cell Biochem., 80, 229-240.
91. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK and Mao L. (2000). Cancer Res., 50, 4000-4004.
92. Sun SC, Harhaj EW, Xiao G and Good L. (2000). AIDS Res. Hum. Retroviruses, 16, 1591-1596.
93. Suzuki T, Kiato S, Matsushime H and Yoshida M. (1996). EMBO J., 15, 1607-1614.
94. Suzuki T, Narita T, Uchida-Toita M and Yoshida M. (1999). Virology, 259, 384-391.
95. Tanaka Y, Mine S, Figdor CG, Wake A, Hirano H, Tsukada J, Aso M, Fujii K, Saito K, van Kooyk Y and Eto S. (1998). Blood, 91, 3909-3919.
96. Taylor WR, DePrimo SE, Agarwal A, Agarwal ML, Schonthal AH, Katula KS and Stark GR. (1999). Mol. Biol. Cell, 10, 3607-3622.
97. Taylor WR and Stark GR. (2001). Oncogene, 20, 1803-1815.
98. Tirnauer JS and Bierer BE. (2000). J. Cell Biol., 149, 761-766.
99. Tsukasaki K, Koeffler P and Tomonaga M. (2000). Baillieres Best Pract. Res. Clin. Haematol., 13, 231-243.
100. Tsukasaki K, Krebs J, Nagai K, Tomonaga M, Koeffler HP, Bartram CR and Jauch A. (2001). Blood, 97, 3875-3881.
101. Vidal AE, Boiteux S, Hickson ID and Radicella JP. (2001). EMBO J., 20, 6530-6539.
102. Wang IK, Lin-Shiau SY and Lin JK. (2000). Pharmacol. Toxicol., 86, 83-91.
103. Weinert T. (1997). Science, 277, 1450-1451.
104. Xiao G, Harhaj EW and Sun SC. (2000). J. Biol. Chem., 275, 34060-34067.
105. Xiao G and Sun SC. (2000). Oncogene, 19, 5198-5203.
106. Yamagata T, Nishida J, Tanaka T, Sakai R, Mitani K, Yoshida M, Taniguchi T, Yazaki Y and Hirai H. (1996). Mol. Cell. Biol., 16, 1283-1294.
107. Yao J and Wigdahl B. (2000). Front Biosci., 5, D138-D168.
108. Yoshida M. (2001). Annu. Rev. Immunol., 19, 475-496.